Share on Pinterest A new study compares the risks and benefits of using GLP-1 medications. Iuliia Burmistrova/Getty Images The use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) for ...
including several newly found conditions linked to the GLP-1 class of weight loss and diabetes drugs. However, the new study led by Ziyad Al-Aly, a physician-scientist at the Veterans Affairs St ...
Popular GLP-1 medications approved for weight loss, diabetes ... as well as how they compare to treatments that are already available. There’s at least one study underway to try to answer ...
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...
The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss ...
GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites ... Another report from Circana found that GLP-1 users traditionally spent more at c-stores ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback